The dynamics of pharma outsourcing and location decisions in Asia are changing. Cost reduction is being augmented and companies need to set their strategic sights on a future world. This new report from PwC highlights the dramatic change and development in pharmaceutical outsourcing in Asia.
The report, *The changing dynamics of pharma outsourcing in Asia* , covers three significant developments- the trend towards high end innovation, rapid expansion of clinical trials in Asia, and a scaling up of pharma manufacturing in Asia.
Key highlights:
– strategic context of outsourcing and location decision in Asia – moving up the value chain and expansion of clinical trials: the changing nature of pharma outsourcing in Asia – overview of Asian regions by three key dimensions: cost, risk and market opportunity
Ref and Read more: http://www.pwc.com/gx/en/pharma-life-sciences/outsourcing/index.jhtml